Jocelyn Hewitt, MD
Endocrinology, Diabetes & Metabolism · Mobile, ALNPI 1407047129
Payments from drug & device makers
Across 574 payments — averaging $15.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Lilly USA, LLC$1K
- Abbott$620
- Amgen$586
- Medtronic$520
- Bayer$447
- plus $4K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 185 | $2,037 |
| Lilly USA, LLC | 68 | $1,286 |
| Abbott | 29 | $620 |
| Amgen(2 entities) | 36 | $586 |
| Medtronic(2 entities) | 26 | $520 |
| Bayer | 30 | $447 |
| Dexcom, Inc. | 36 | $349 |
| AstraZeneca | 19 | $345 |
| Boehringer Ingelheim | 19 | $309 |
| Corcept Therapeutics | 18 | $306 |
| Sanofi-aventis U.S. LLC | 14 | $265 |
| BETA Bionics, Inc. | 9 | $261 |
| Xeris Pharmaceuticals, Inc. | 12 | $256 |
| Novartis | 9 | $238 |
| Insulet Corporation | 9 | $221 |
| AbbVie(2 entities) | 12 | $207 |
| Rochester Medical Corporation | 4 | $86 |
| BD | 3 | $86 |
| Amneal Pharmaceuticals LLC | 4 | $66 |
| Esperion Therapeutics, Inc. | 4 | $60 |
| Lifescan, Inc. | 4 | $54 |
| Merck | 3 | $48 |
| Antares Pharma, Inc. | 3 | $48 |
| Radius Health, Inc. | 2 | $40 |
| Tandem Diabetes Care, Inc. | 2 | $39 |
| Pfizer | 2 | $36 |
| IBSA Pharma Inc. | 2 | $34 |
| Amryt Pharma Holdings Ltd | 1 | $23 |
| Chiesi USA, Inc. | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| EUSA Pharma (US) LLC | 1 | $21 |
| Recordati_rare_diseases_inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| GRT US Holding, Inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Averitas Pharma Inc. | 1 | $15 |
How this compares
$9,044 in reported general payments places this provider in the 55th percentile of 79 endocrinology, diabetes & metabolism providers in Alabama.
See all endocrinology, diabetes & metabolism providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Mobile
- Wilburn BoltonMobile$52K
- Anita KemmerlyMobile$13K
- Michael DavisMobile$12K
- Heather FishelMobile$11K
- Michael GalitzMobile$10K
- Huey McDanielMobile$8K
- Stephen DavisMobile$7K
- Ross del FierroMobile$6K
- Jessica BhathalMobile$6K
- William GarveyBirmingham$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.